Espina Virginia, Woodhouse Elisa C, Wulfkuhle Julia, Asmussen Heather D, Petricoin Emanuel F, Liotta Lance A
FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Room B1B53, Bldg. 10, 9000 Rockville Pike, Bethesda, MD 20892, USA.
J Immunol Methods. 2004 Jul;290(1-2):121-33. doi: 10.1016/j.jim.2004.04.013.
Protein microarrays are being utilized for functional proteomic analysis, providing information not obtainable by gene arrays. Microarray technology is applicable for studying protein-protein, protein-ligand, kinase activity and posttranslational modifications of proteins. A precise and sensitive protein microarray, the direct detection or reverse-phase microarray, has been applied to ongoing clinical trials at the National Cancer Institute for studying phosphorylation events in EGF-receptor-mediated cell signaling pathways. The variety of microarray applications allows for multiple, creative microarray designs and detection strategies. Herein, we discuss detection strategies and challenges for protein microarray technology, focusing on direct detection of protein microarrays.
蛋白质微阵列正被用于功能蛋白质组学分析,提供基因阵列无法获得的信息。微阵列技术适用于研究蛋白质-蛋白质、蛋白质-配体、激酶活性以及蛋白质的翻译后修饰。一种精确且灵敏的蛋白质微阵列,即直接检测或反相微阵列,已应用于美国国立癌症研究所正在进行的临床试验,用于研究表皮生长因子受体介导的细胞信号通路中的磷酸化事件。微阵列应用的多样性允许进行多种创新的微阵列设计和检测策略。在此,我们讨论蛋白质微阵列技术的检测策略和挑战,重点关注蛋白质微阵列的直接检测。